Skip to content

Faculty profile

ResearcherPharmacyUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses may be missing. Find their university profile.

Latest papers

  • Based on the gut-heart axis: Polygonum capitatum improves atherosclerosis by modulating gut microbiota and TMAO, supporting MCPIP1/p53-associated endothelial protection.

    Chinese medicine · 2026

  • Mast cell-expressed Mrgprb2/MRGPRX2 mediates gout pain and inflammation via a neuroimmune axis.

    JCI insight · 2026

  • Salidroside protects against myocardial infarction via activating MIF-mediated mitochondrial quality control.

    Chinese medicine · 2025

All 17 publications

Latest funding

  • TAAR1 in adipose tissue is a novel therapeutic target to combat atypical antipsychotics (AAPs)-induced metabolic dysfunction via downregulation of MIF

    CIHR · 2024 · Nominated PI

    $849,150
All 1 grants and awards
Something wrong or missing on this profile? Suggest a correction